Sarcopenia and Osteoporosis in the Patients With Hemophilia

CompletedOBSERVATIONAL
Enrollment

45

Participants

Timeline

Start Date

January 1, 2019

Primary Completion Date

December 31, 2019

Study Completion Date

December 31, 2019

Conditions
SarcopeniaHemophiliaOsteoporosis, OsteopeniaHemophilic Arthropathy
Interventions
DIAGNOSTIC_TEST

Dual-energy X-ray absorptiometry (DXA)

"Body composition will be measured using whole-body DXA (GE Lunar iDXA, GE Healthcare Lunar, Madison, Wisconsin, U.S.A.). Extremity skeletal muscle mass will be calculated using the values measured via the DXA; ASM will be calculated as the sum of skeletal muscle mass in the arms and legs, assuming that the mass of lean soft tissue is a skeletal muscle. Appendicular skeletal mass index (ASM/Ht2 ) will be determined as the sum of the arm and leg lean mass (kg)/height2 (m2~). BMD will be measured in lumbar spine and bilateral hip by the same DXA device (GE Lunar iDXA, GE Healthcare Lunar, Madison, Wisconsin, U.S.A.)"

Trial Locations (1)

114

Tri-Service General Hospital, Taipei

All Listed Sponsors
lead

Tri-Service General Hospital

OTHER

NCT04535180 - Sarcopenia and Osteoporosis in the Patients With Hemophilia | Biotech Hunter | Biotech Hunter